Zambon S.p.a.

Zambon Group

Alessandra De Lazzari

Alberto Moretto

Luca Rampoldi

Alessandro Grassano

Fabiana Mazzara

Deborah Teoli

Lucia Dicorato

The present invention relates to pharmaceutical compositions comprising safinamide and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.

Pharmaceutical compositions comprising safinamide

The present invention relates to pharmaceutical compositions comprising safinamide, and, more particularly, to taste-masked particles comprising said active ingredient or pharmaceutically acceptable salts thereof, oral dosage forms that include said particles and a process for preparing them.

This invention relates to swallowable tablets containing at least 80% by weight of N-acetylcysteine (NAC) and at least one pharmaceutically acceptable excipient, in particular tablets in which the sulfurous odor is absent, characterized in that the said tablets are assembled using a granulate prepared by means of a process of dry granulating the active ingredient alone, with which the excipients are mixed before compression.

Growing community of inventors

Padua, Italy

Alessandra De Lazzari